About Elanco Animal Health Incorporated
https://www.elanco.comElanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.
CEO
Jeffrey N. Simmons
Compensation Summary
(Year 2022)
ETFs Holding This Stock
Summary
Showing Top 3 of 217
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
UBS
Buy
Stifel
Buy
Leerink Partners
Outperform
William Blair
Outperform
JP Morgan
Overweight
Barclays
Overweight
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
DODGE & COX
Shares:82.76M
Value:$2.02B
FMR LLC
Shares:65.36M
Value:$1.6B
PRIMECAP MANAGEMENT CO/CA/
Shares:49.96M
Value:$1.22B
Summary
Showing Top 3 of 505
About Elanco Animal Health Incorporated
https://www.elanco.comElanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.14B ▼ | $580M ▲ | $-34M ▼ | -2.99% ▼ | $-0.07 ▼ | $178M ▼ |
| Q2-2025 | $1.24B ▲ | $492M ▲ | $11M ▼ | 0.89% ▼ | $0.02 ▼ | $264M ▼ |
| Q1-2025 | $1.19B ▲ | $435M ▲ | $67M ▲ | 5.62% ▲ | $0.14 ▲ | $274M ▲ |
| Q4-2024 | $1.02B ▼ | $381M ▼ | $-8M ▼ | -0.78% ▼ | $-0.02 ▼ | $175M ▼ |
| Q3-2024 | $1.03B | $410M | $364M | 35.34% | $0.74 | $814M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $505M ▼ | $13.55B ▼ | $6.8B ▼ | $6.75B ▼ |
| Q2-2025 | $539M ▲ | $13.74B ▲ | $6.97B ▲ | $6.78B ▲ |
| Q1-2025 | $487M ▲ | $12.94B ▲ | $6.59B ▲ | $6.35B ▲ |
| Q4-2024 | $468M ▼ | $12.61B ▼ | $6.52B ▼ | $6.1B ▼ |
| Q3-2024 | $490M | $13.28B | $6.76B | $6.52B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-34M ▼ | $219M ▼ | $-101M ▼ | $-153M ▲ | $-34M ▼ | $127M ▼ |
| Q2-2025 | $11M ▼ | $237M ▲ | $-56M ▲ | $-156M ▼ | $52M ▲ | $180M ▲ |
| Q1-2025 | $67M ▲ | $-4M ▼ | $-58M ▲ | $52M ▲ | $19M ▲ | $-69M ▼ |
| Q4-2024 | $-8M ▼ | $177M ▲ | $-90M ▼ | $-32M ▲ | $-22M ▼ | $124M ▲ |
| Q3-2024 | $364M | $162M | $1.24B | $-1.34B | $74M | $120M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Cattle | $510.00M ▲ | $270.00M ▼ | $270.00M ▲ | $290.00M ▲ |
 Contract Manufacturing | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 Farm Animal | $1.16Bn ▲ | $550.00M ▼ | $580.00M ▲ | $590.00M ▲ |
 Pet Health | $1.02Bn ▲ | $640.00M ▼ | $640.00M ▲ | $530.00M ▼ |
 Poultry | $410.00M ▲ | $190.00M ▼ | $210.00M ▲ | $220.00M ▲ |
 Swine | $190.00M ▲ | $90.00M ▼ | $100.00M ▲ | $90.00M ▼ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 NonUS | $550.00M ▲ | $590.00M ▲ | $640.00M ▲ | $650.00M ▲ |
 UNITED STATES | $470.00M ▲ | $550.00M ▲ | $550.00M ▲ | $590.00M ▲ |
CEO
Jeffrey N. Simmons
Compensation Summary
(Year 2022)
ETFs Holding This Stock
Summary
Showing Top 3 of 217
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
UBS
Buy
Stifel
Buy
Leerink Partners
Outperform
William Blair
Outperform
JP Morgan
Overweight
Barclays
Overweight
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
DODGE & COX
Shares:82.76M
Value:$2.02B
FMR LLC
Shares:65.36M
Value:$1.6B
PRIMECAP MANAGEMENT CO/CA/
Shares:49.96M
Value:$1.22B
Summary
Showing Top 3 of 505